Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0006772
Title: Utilization of genomic signatures to identify phenotype-specific drugs
Authors: Mori, S. 
Chang, J.T.
Andrechek, E.R.
Potti, A.
Nevins, J.R.
Issue Date: 28-Aug-2009
Citation: Mori, S., Chang, J.T., Andrechek, E.R., Potti, A., Nevins, J.R. (2009-08-28). Utilization of genomic signatures to identify phenotype-specific drugs. PLoS ONE 4 (8) : -. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0006772
Abstract: Genetic and genomic studies highlight the substantial complexity and heterogeneity of human cancers and emphasize the general lack of therapeutics that can match this complexity. With the goal of expanding opportunities for drug discovery, we describe an approach that makes use of a phenotype-based screen combined with the use of multiple cancer cell lines. In particular, we have used the NCI-60 cancer cell line panel that includes drug sensitivity measures for over 40,000 compounds assayed on 59 independent cells lines. Targets are cancer-relevant phenotypes represented as gene expression signatures that are used to identify cells within the NCI-60 panel reflecting the signature phenotype and then connect to compounds that are selectively active against those cells. As a proof-of-concept, we show that this strategy effectively identifies compounds with selectivity to the RAS or PI3K pathways. We have then extended this strategy to identify compounds that have activity towards cells exhibiting the basal phenotype of breast cancer, a clinically-important breast cancer characterized as ER-, PR-, and Her2- that lacks viable therapeutic options. One of these compounds, Simvastatin, has previously been shown to inhibit breast cancer cell growth in vitro and importantly, has been associated with a reduction in ER-, PR- breast cancer in a clinical study. We suggest that this approach provides a novel strategy towards identification of therapeutic agents based on clinically relevant phenotypes that can augment the conventional strategies of target-based screens. © 2009 Mori et al.
Source Title: PLoS ONE
URI: http://scholarbank.nus.edu.sg/handle/10635/115350
ISSN: 19326203
DOI: 10.1371/journal.pone.0006772
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

22
checked on Jan 18, 2021

WEB OF SCIENCETM
Citations

19
checked on Jan 18, 2021

Page view(s)

80
checked on Jan 16, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.